XML 35 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Significant Accounting Policies - Cumulative Effective Adopted Accounting Pronouncement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Jan. 01, 2018
Dec. 31, 2017
Deferred collaboration expense $ 152   $ 152 $ 210
Deferred revenue 7,300   7,300 8,484
Accumulated deficit (656,494)   (630,717) $ (631,843)
Revenues 3,976 $ 9,437    
Research and development 18,441 16,770    
Net loss $ (25,777) $ (14,219)    
Basic and diluted net loss per common share (in dollars per share) $ (0.26) $ (0.19)    
Accounting Standards Update 2014-09 [Member]        
Deferred collaboration expense     (58)  
Deferred revenue     (1,184)  
Accumulated deficit     $ 1,126  
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]        
Deferred collaboration expense $ 44      
Deferred revenue 888      
Accumulated deficit 282      
Research and development 14      
Net loss $ 282      
Basic and diluted net loss per common share (in dollars per share) $ 0      
Calculated under Revenue Guidance in Effect before Topic 606 [Member]        
Deferred collaboration expense $ 196      
Deferred revenue 8,188      
Accumulated deficit (656,212)      
Research and development 18,455      
Net loss $ (25,495)      
Basic and diluted net loss per common share (in dollars per share) $ (0.26)      
Collaborative and Other Research and Development [Member]        
Revenues $ 315 $ 3,116    
Collaborative and Other Research and Development [Member] | Difference between Revenue Guidance in Effect before and after Topic 606 [Member]        
Revenues 296      
Collaborative and Other Research and Development [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]        
Revenues $ 611